Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biogen

Clinical trials sponsored by Biogen, explained in plain language.

Biogen BIIB NASDAQ

A biotechnology company focused on neurological diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 18 Not yet recruiting 1 Not yet finished but already full! 20 Completed 14 Terminated 2

New hope for kids with MS: safer drug combo aims to stop relapses

Disease control Not yet recruiting

This study tests two drugs, diroximel fumarate and dimethyl fumarate, in children with relapsing multiple sclerosis. About 185 kids will be split by weight and randomly assigned to one of the drugs or a standard treatment (fingolimod). The goal is to see which drug is safer and b…

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC